Description
Survodutide is a dual GLP-1/glucagon receptor agonist originally developed for research into metabolic dysfunction-associated steatotic liver disease (MASLD) as well as obesity. Its glucagon-receptor activity is specifically of interest to hepatology-adjacent research, since glucagon signalling influences hepatic fat oxidation independently of the appetite-suppressing GLP-1 pathway.
Because survodutide sits at the intersection of metabolic and liver-disease research, it’s frequently requested by labs studying fatty liver models alongside classic obesity endpoints — a narrower and more specific research niche than single-pathway GLP-1 compounds.
After you place your order, a licensed physician will speak with you directly on a live call to review your health history and confirm a prescription is medically appropriate before anything ships. If your order isn’t approved, our team will contact you directly instead of shipping it. Reconstitute with bacteriostatic water and store refrigerated per standard peptide handling.
